Skip to main content

Psoriatic arthritis

Low Risk of TB with Secukinumab

Jan 20, 2021

JAMA Dermatology has reported on a longitudinal cohort study of 12,319 secukinumab (SEC) treated patients (psoriasis, psoriatic arthritis, or ankylosing spondylitis); no new cases of active tuberculosis (TB) and very few cases of latent tuberculosis infection (LTBI) were found. 

Read Article
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE
Dr. John Cush RheumNow ( View Tweet)
Jan 16, 2021

2020 Rheumatology Year in Review

Jan 14, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article
ACR Convergence 2020 Fireside Chats – Top presentations in nr-axSpA, AS, axial PsA Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at #ACR20?
Dr. John Cush RheumNow ( View Tweet)
Jan 14, 2021

Delays in Diagnosis of Axial Spondyloarthritis

Jan 12, 2021

The diagnosis of axial spondyloarthritis (and anklylosing spondylitis) (axSpA) is often delayed and usually not diagnosed by rheumatologists; a recent metanalysis shows that longer delays were attributable to lower education levels, younger age at onset and absence of extra-articular

Read Article
National Psoriasis Foundation Task Force updated their COVID-19 guidance statements.

Dr. John Cush RheumNow ( View Tweet)

Jan 11, 2021
ACR Convergence 2020 Late Breaking Abstracts available from the ACR "Spotlight" slide give away. 10 slides on COVID, Tyk2 in PsA, FAST febuxostat study, Tofa in AS and novel drugs for SLE and PSS https://t.co/DvcDyusCUR

Dr. John Cush RheumNow ( View Tweet)

Jan 11, 2021
ACR Convergence 2020 Fireside Chats – Top presentations in nr-axSpA, AS, axial PsA Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at #ACR20?
Dr. John Cush RheumNow ( View Tweet)
Jan 10, 2021
Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/NDhYNX50e2

Dr. John Cush RheumNow ( View Tweet)

Jan 09, 2021

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Jan 08, 2021

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.

Read Article
Spinal Benefits Seen With Cosentyx in PsA---Secukinumab (Cosentyx) was effective for axial manifestations of psoriatic arthritis in a 52-week multicenter phase III study, investigators reported. https://t.co/OfkQtAO9Gh https://
Dr. John Cush RheumNow ( View Tweet)
Jan 07, 2021

EULAR Guidance on Patient Adherence to Meds

Jan 06, 2021

Non-adherence may be the single most untold risk to suboptimal outcomes in the care of musculoskeletal disease.  It has been estimated that 30-80% of patients with rheumatic and musculoskeletal diseases (RMDs) are nonadherent to prescribed regimens.  EULAR has commissioned a task force to

Read Article
Broadalumab the other IL-17 inhibitor, is FDA approved for psoriasis. The AMVISION-1 & AMVISION-2 ph III trials in psoriatic arthritis showed in 962 PsA pts it was effective w/ week 16 ACR20 of ~46% (vs 21% PBO).

Dr. John Cush RheumNow ( View Tweet)

Jan 06, 2021

Spinal Benefits Seen With Cosentyx in PsA

MedPage Today
Jan 05, 2021

Secukinumab (Cosentyx) was effective for axial manifestations of psoriatic arthritis in a 52-week multicenter phase III study, investigators reported.



The primary endpoint of a 20% response on the criteria of the Assessment of Spondyloarthritis International Society (ASAS20) at week

Read Article
Join us this March for RheumNow Live! Sign up via the link below. https://t.co/vJlU0Z3Q3x https://t.co/G1s3F7zKlI
Dr. John Cush RheumNow ( View Tweet)
Jan 05, 2021

ACR 2020 Reproductive Guidelines - Medication Use with Pregnancy (Best of 2020)

Dec 30, 2020

The ACR has published guidelines to manage reproductive health issues in rheumatic disease (RMD) patients before, during and after pregnancy. In this second excerpt from their guidelines articles, we present recommendations (and good clinical practice statements) for paternal rheumatology

Read Article

ACR 2020 Reproductive Guidelines - Lactation Guidance (Best of 2020)

Dec 30, 2020

In this third excerpt from the ACR guidelines on managing reproductive health issues in rheumatic disease patients, we present recommendations regarding the use of glucocorticoids and guidance on lactation and medication use post-partum.

Read Article

Best of 2020: ACR 2020 Reproductive Guidelines - Contraception & Counseling

Dec 29, 2020

The American College of Rheumatology established a guidelines committee that consisted of both patients, rheumatologists and maternal-fetal health experts. After a a systematic review of the medical literature regarding contraception, assisted reproductive technology, fertility preservation,

Read Article
#BestACR20Tweets Presented at EADV Dermatology Congress - Mirikizumab, IL-23 inhibitor, shown superior to placebo & Secukinumab in Psoriasis. 465 patients given either PBO, MIR (2 doses) or SEC.
Dr. John Cush RheumNow ( View Tweet)
Dec 27, 2020

Best of 2020: The COVID-19 Global Rheumatology Registry

Dec 24, 2020

What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease

Read Article
#BestACR20Tweets RT @uptoTate : Claims-based "big data" reveals PsA pts had "arthritis" coding prior to formal dx and coding for enthesitis, axial dz, and arthritis increased prior to PsA dx. Coding diff between treating specialties also noted.
Dr. John Cush RheumNow ( View Tweet)
Dec 24, 2020

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Dec 23, 2020

Ready for telemedicine/telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

Read Article
#BestACR20Tweets RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ significantly greater TJC, SJC, CRP, US synovitis/erosions in very early DMARD naïve pts.
Dr. John Cush RheumNow ( View Tweet)
Dec 23, 2020
Psoriatic Arthritis Panel Discussion Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty discuss novel issues and new drug studies from #ACR20. https://t.co/KLEBuWNHkn https://t.co/ERIT7f9rNq
Dr. John Cush RheumNow ( View Tweet)
Dec 22, 2020

Best of 2020: Rheumatic Disease Drugs and COVID-19

Dec 22, 2020

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most

Read Article
×